
Douglas Jennings
At Pacific Since: 2025
Douglas Jennings, PharmD, FCCP, FAHA, FACC, FHFSA earned his doctor of pharmacy from Wayne State University in Detroit and completed a postgraduate year one residency at Medical University of South Carolina. He went on to complete a postgraduate year two cardiovascular specialty residency at Henry Ford Hospital in Detroit.
Dr. Jennings is an experienced classroom and experiential educator and accomplished researcher. His clinical expertise centers on advanced heart failure and transplantation, where he has dedicated his career to improving outcomes for critically ill patients. He finds it especially rewarding to help transplant recipients learn to care for their new hearts and his research focuses on optimizing the use of immunosuppressants. This work is regarded as one of the highlights of his career. He has also been invited to share his expertise at conferences in six different countries.
He is actively involved in several professional organizations, including the American College of Clinical Pharmacy, the American Heart Association, the American College of Cardiology, the Heart Failure Society of America and the American Society of Health-System Pharmacists, among others.
Prior to Pacific, Dr. Jennings served as professor and department chair of pharmacy practice at Long Island University Arnold and Maria Schwartz College of Pharmacy and Health Sciences. He has also served as an assistant clinical professor of pharmacy sciences at Columbia University College of Nursing in New York and as a clinical pharmacist on the Heart Transplant and LVAD team at New York-Presbyterian/Columbia University Irving Medical Center. In addition, Dr. Jennings served on the faculty at Nova Southeastern University College of Pharmacy and Wayne State University College of Pharmacy.
Outside of his professional work, Dr. Jennings enjoys yoga, golf and NFL football.
PharmD, Wayne State University in Detroit
Pharmacy Practice Residency, Medical University of South Carolina
Cardiovascular Specialty Residency, Henry Ford Hospital in Detroit
- Optimizing immunosuppression regimens for patients recovering from heart transplant surgery
- Optimizing drug therapy regimens for patients recovering from MCS (mechanicalcirculatory support) surgery
- Exploring the link between the gut microbiome and key immunosuppressant medications